Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, dal 1982 In collaborazione con l'Associazione Culturale Pediatri

Caso contributivo

PDF MeBrain

Sindrome DRESS: da un caso clinico particolare alla rivisitazione della patologia

DRESS syndrome

Sergio Manieri, Fabiola De Gregorio, Maria Pia Mirauda, Carmela Colangelo, Maria Tagliente, Rosaria Abate, Luciana Romaniello, Rosa Lapolla, Donatello Salvatore
UOC di Pediatria, Ospedale San Carlo, Potenza

Gennaio 2022 | DOI: 10.53126/MEBXXV010

Abstract
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe multiorgan hypersensitivity reaction mostly caused by several eliciting drugs in patients with a genetic predisposition. Anti-convulsants are the main drugs involved both in adults and in children. Incidence of DRESS in children is very variable, from 1:1,000 to 1:10,000, and the mortality rate seems to be lower than 10%. The treatment of choice is the prompt withdrawn of the offending drug and using intravenous immunoglobulins and corticosteroids used in synergy. In recent years, emerging studies have outlined the disease more clearly. We present a paediatric case in which the patient developed DRESS syndrome as a result of exposure to lamotrigine before and carbamazepine after and a relapse after exposure to omeprazole. Starting from this case report we provide an overview on DRESS syndrome.
Riassunto
La sindrome DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) è una grave reazione di ipersensibilità multiorgano indotta da diversi farmaci in pazienti con predisposizione genetica. Gli anticonvulsivanti sono i principali farmaci coinvolti sia negli adulti sia nei bambini. L’incidenza della DRESS nei bambini è molto variabile, da 1 su 1000 a 1 su 10.000, e il tasso di mortalità sembra essere inferiore al 10%. Il trattamento di scelta è la pronta sospensione del farmaco responsabile e, nelle forme severe, l’utilizzo di corticosteroidi, sebbene ci sono alcune segnalazioni circa l’uso, in associazione agli steroidi, di immunoglobuline endovena. Negli ultimi anni, studi emergenti hanno delineato più chiaramente la malattia. Presentiamo un caso pediatrico in cui il paziente ha sviluppato la sindrome DRESS a seguito della somministrazione di lamotrigina prima e di carbamazepina poi, e una ricaduta dopo somministrazione di omeprazolo. Partendo da questo caso clinico viene riportata una panoramica della sindrome DRESS.
Contenuto riservato

Per leggere l'articolo è necessario effettuare il login.

Per l'acquisto del singolo articolo scrivi a abbonamenti@medicoebambino.com (la mail si prepara da sola con gli estremi dell'articolo); se accedi, la richiesta parte con un click.

Bibliografia

  1. Bocquet H, Bogot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996;15(4):250-7. doi: 10.1016/s1085-5629(96)80038-1.
  2. Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med 2011;124(7):588-97. doi: 10.1016/j.amjmed.2011.01.017.
  3. Mori F, Caffarelli C, Caimmi S, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS) in children. Acta Biomed 2019;90(Suppl 3):66–79. doi: 10.23750/abm.v90i3-S.8167.
  4. Cho YT, Yang CW, Chu CY. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): an interplay among drugs, viruses, and immune system. Int J Mol Sci 2017;18(6):1243. doi: 10.3390/ijms18061243.
  5. Peyrière H, Dereure O, Breton H, et al.; The Network of Pharmacovigilance Centers. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2006;155(2):422-8. doi: 10.1111/j.1365-2133.2006.07284.x.
  6. Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 2013;169(5):1071-80. doi: 10.1111/bjd.12501.
  7. Lee T, Lee YS, Yoon SY, et al. Characteristics of liver injury in drug-induced systemic hypersensitivity reactions. J Am Acad Dermatol 2013;69(3):407-15. doi: 10.1016/j.jaad.2013.03.024.
  8. Danan G, Benichou C. Causality assessment of adverse reactions to drugs-1. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol 1993;46(11):1323-30. doi: 10.1016/0895-4356(93)90101-6.
  9. Kano Y, Ishida T, Hirahara K, Shiohara T. Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome. Med Clin North Am 2010;94(4):743-59, xi. doi: 10.1016/j.mcna.2010.03.004.
  10. Thongsri T, Chularojanamontri L, Pichler WJ. Cardiac involvement in DRESS syndrome. Asian Pac J Allergy Immunol 2017;35(1):3-10. doi: 10.12932/AP0847.
  11. Bourgeois GP, Cafardi JA, Groysman V, Hughey LC. A review of DRESS-associated myocarditis. J Am Acad Dermatol 2012;66(6):e229-36. doi: 10.1016/j.jaad.2010.11.057.
  12. Ozisik, L, Tanriover MD, Saka E. Autoimmune limbic encephalitis and syndrome of inappropriate antidiuretic hormone secretion associated with lamotrigine-induced drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Intern Med 2016;55(10):1393-6. doi: 10.2169/internalmedicine.55.6035.
  13. Picard D, Vellar M, Janela B, Roussel A, Joly P, Musette P. Recurrence of drug-induced reactions in DRESS patients. J Eur Acad Dermatol Venereol 2015;29(4):801-4. doi: 10.1111/jdv.12419.
  14. Roujeau J-C, Dupin N. Virus reactivation in Drug Reaction with Eosinophilia and Systemic Symp-toms (DRESS) results from a strong drug-specific immune response. J Allergy Clin Immunol Pract 2017;5(3):811-2. doi: 10.1016/j.jaip.2016.11.027.
  15. Yazicioglu M, Elmas R, Turgut B, Genchallac T. Association between DRESS and the diminished numbers of peripheral B lymphocytes and natural killer cells: Peripheral B lymphocytes and NK cells in DRESS. Pediatr Allergy Immunol 2012;23(3):289-96. doi: 10.1111/j.1399-3038.2012.01268.x.
  16. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007;156(3):609-11. doi: 10.1111/j.1365-2133.2006.07704.x.
  17. Chen YC, Cho YT, Chang CY, Chu CY. Drug reaction with eosinophilia and systemic symptoms: a drug-induced hypersensitivity syndrome with variable clinical features. Dermatol Sin 2013;31:196-204. doi: 10.1016/j.dsi.2013.09.006.
  18. Shiohara T, Kano Y. Drug reaction with eosinophilia and systemic symptoms (DRESS): Incidence, pathogenesis, and management. Expert Opin Drug Saf 2017;16(2):139-47. doi: 10.1080/14740338.2017.1270940.
  19. Descamps V, BenSaid B, Sassolas B, et al.; groupe Toxidermies de la Société française de dermatologie. Management of drug reaction with eosinophilia and systemic symptoms (DRESS). Ann Dermatol Venereol 2010;137(11):703-8. doi: 10.1016/j.annder.2010.04.024.
  20. Uhara H, Saiki M, Kawachi S, Ashida A, Oguchi S, Okuyama R. Clinical course of drug-induced hypersensitivity syndrome treated without systemic corticosteroids. J Eur Acad Dermatol Venereol 2013;27(6):722-6. doi: 10.1111/j.1468-3083.2012.04547.x.